Chitosan-Based Dressing as a Sustained Delivery System for Bioactive Cytokines
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms25010030 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sławomir Lewicki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, 03-411 Warsaw, Poland. Hauptthemen laut MEDLINE: Chitosan, Deafness. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for Research and Development.
Abstract (Originalsprache)
Wounds represent a common occurrence in human life. Consequently, scientific investigations are underway to advance wound healing methodologies, with a notable focus on dressings imbued with biologically active compounds capable of orchestrating the wound microenvironment through meticulously regulated release mechanisms. Among these bioactive agents are cytokines, which, when administered to the wound milieu without appropriate protection, undergo rapid loss of their functional attributes. Within the context of this research, we present a method for fabricating dressings enriched with G-CSF (granulocyte colony-stimulating factor) or GM-CSF (granulocyte-macrophage colony-stimulating factor), showcasing both biological activity and protracted release dynamics. Based on Ligasano, a commercial polyurethane foam dressing, and chitosan crosslinked with TPP (sodium tripolyphosphate), these dressings are noncytotoxic and enable cytokine incorporation. The recovery of cytokines from dressings varied based on the dressing preparation and storage techniques (without modification, drying, freeze-drying followed by storage at 4 °C or freeze-drying followed by storage at 24 °C) and cytokine type. Generally, drying reduced cytokine levels and their bioactivity, especially with G-CSF. The recovery of G-CSF from unmodified dressings was lower compared to GM-CSF (60% vs. 80%). In summary, our freeze-drying approach enables the storage of G-CSF or GM-CSF enriched dressings at 24 °C with minimal cytokine loss, preserving their biological activity and thus enhancing future clinical availability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, 03-411 Warsaw, Poland.
- Faculty of Medical Sciences and Health Sciences, Kazimierz Pulaski University of Radom, 26-600 Radom, Poland.
- Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Clinical Research and Development, LUX MED Group, 02-676 Warsaw, Poland.
- Military Centre of Preventive Medicine, 05-100 Nowy Dwór Mazowiecki, Poland.
- Department of Regenerative Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
ORCID-Profile: Sławomir Lewicki, Michał Zwoliński, Łukasz Szarpak, Aneta Lewicka, Łukasz Szymański
Förderung
- National Centre for Research and Development
Zitieren
APA
Lewicki, S., Zwoliński, M., Hovagimyan, A., Stelmasiak, M., Szarpak, Ł., Lewicka, A., Pojda, Z., & Szymański, Ł. (2023). Chitosan-Based Dressing as a Sustained Delivery System for Bioactive Cytokines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010030
Vancouver
Lewicki S, Zwoliński M, Hovagimyan A, Stelmasiak M, Szarpak Ł, Lewicka A, et al. Chitosan-Based Dressing as a Sustained Delivery System for Bioactive Cytokines. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms25010030
BibTeX
@article{Lewicki2023,
author = {Lewicki, Sławomir and Zwoliński, Michał and Hovagimyan, Adrian and Stelmasiak, Marta and Szarpak, Łukasz and Lewicka, Aneta and Pojda, Zygmunt and Szymański, Łukasz},
title = {Chitosan-Based Dressing as a Sustained Delivery System for Bioactive Cytokines},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms25010030}
}
EUVIMED